One Global Service Provider Ltd514330Corporate

Healthcare Service Provider Latest results: Jun 2026 14 quarters of data
₹521.45
MCap ₹1,043 Cr · P/E 14.0
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹103 Cr
Sales · Jun 2026
+16.8% YoY
₹19 Cr
Operating Profit · Jun 2026
+47.5% YoY
18.7%
OPM % · Jun 2026
+26.4% YoY
₹14 Cr
Net Profit · Jun 2026
+43.0% YoY
₹7.32
EPS · Jun 2026
-47.0% YoY

📝 One Global Service Provider Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

One Global Service Provider Ltd reported revenue of ₹103 crore for the quarter ended June 2026 (Q1 FY27), up 16.8% from ₹88 crore in the same quarter last year, and down 23.3% sequentially over the March 2026 quarter.

Net profit rose 43.0% year-on-year to ₹14 crore, from ₹10 crore. Earnings per share (EPS) came in at ₹7.32.

Operating profit stood at ₹19 crore — an operating margin (OPM) of 18.7%, compared with 14.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, One Global Service Provider Ltd posted revenue of ₹498 crore, a growth of 311.6% over FY25, with a net profit of ₹70 crore (up 288.9% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹513 crore with a net profit of ₹74 crore.

Valuation snapshot

At the current price of ₹521.45, 514330 has a market capitalisation of ₹1,043 crore and a trailing P/E of about 14.0.

Within the Healthcare Service Provider industry, it is the 3rd-largest of the 20 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 68.40%, foreign institutional investors (FIIs) 7.72%, domestic institutional investors (DIIs) 0.01%, public shareholders 23.87% of One Global Service Provider Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,043 Cr
Current Price ?
₹521.5
P/E ?
14.04below ind
Industry P/E ?
22.50
P/B ?
7.34
P/S ?
2.03
P/FCF ?
347.63
Enterprise Value ?
₹1,043 Cr
EV/EBITDA ?
10.62
PEG ?
0.05
Earnings Yield ?
9.4%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹513 Cr
OPM ?
19.1%
Profit after tax (TTM) ?
₹74 Cr
EPS (TTM) ?
₹37.15
ROCE ?
87.0%
ROE ?
52.3%
ROA ?
29.1%
Growth
Sales — latest qtr ?
₹103 Cr
PAT — latest qtr ?
₹14 Cr
YoY qtr sales growth ?
16.8%
YoY qtr profit growth ?
43.0%
Sales growth (3y) ?
202%
Sales growth (5y) ?
167%
Profit growth (3y) ?
269%
Profit growth (5y) ?
97%
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
68.40%
Change in promoter holding ?
2.16%
Pledged percentage ?
N/A
Market
Return 3 months ?
-24.9%
Return 6 months ?
-7.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 5131215241419335588135141134103 +16.8% -23.3%
Operating Profit 11125235151326292419 +47.5% -20.1%
Other Income 00000000000000 — —
Interest 0000000000000— — —
Depreciation 00000000000000 — —
Profit Before Tax 01125235151326292419 +46.7% -20.6%
Net Profit 01114223111020221814 +43.0% -20.6%
EPS 0.621.380.972.055.592.483.204.9015.4813.8210.1311.089.317.32 -47.0% -21.4%
OPM % 20.0% 7.7% 8.3% 13.3% 20.8% 14.3% 15.8% 15.2% 27.3% 14.8% 19.3% 20.6% 17.9% 18.7% +26.4% +4.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹121 Cr ₹498 Cr ₹513 Cr +311.6%
Operating Profit ₹25 Cr ₹92 Cr ₹98 Cr +268.0%
OPM % 20.66% 18.47% 19.15% -10.6%
NPM % 14.88% 14.06% 14.49% -5.5%
Other Income ₹0 Cr ₹0 Cr ₹0 Cr —
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr —
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹25 Cr ₹92 Cr ₹98 Cr +268.0%
PBT ₹25 Cr ₹92 Cr ₹98 Cr +268.0%
Tax — — ₹5 Cr —
Net Profit ₹18 Cr ₹70 Cr ₹74 Cr +288.9%
EPS ₹26.06 ₹44.34 ₹37.84 +70.1%
Material Cost — — ₹80 Cr —
Employee Cost — — ₹1 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 772020 +0.0%
Reserves 0752122 +134.6%
Borrowings 0000 —
Other Liabilities 51734114 +235.3%
Total Liabilities 1332106255 +140.6%
Fixed Assets 1122 +0.0%
CWIP 330-0 —
Investments -0-0-00 —
Other Assets 928104253 +143.3%
Total Assets 1332106255 +140.6%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 01143 -78.6%
Cash from Investing Activity -0-0-0-0 —
Cash from Financing Activity -0-0-1-0 +100.0%
Net Cash Flow -01142 -85.7%
Free Cash Flow -01143 -78.6%
CFO/OP 8%12%67%10% -85.1%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 164152134159 +18.7%
Inventory Days -0-0-00 —
Days Payable ———98 —
Cash Conversion Cycle 16415213460 -55.2%
Working Capital Days 76575977 +30.5%
ROCE % 20%85%56%87% +55.4%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 66.24%68.38%68.40%68.40% +0.0%
FIIs 5.44%5.45%5.44%7.72% +41.9%
DIIs 0.00%0.00%0.01%0.01% +0.0%
Public 28.31%26.16%26.14%23.87% -8.7%
No. of Shareholders 6,4138,0168,4619,204 +8.8%

⚖️ Peer comparison

Industry: Healthcare Service Provider · 20 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NEPHROPLUS Nephrocare Health ₹673.00 6,768 78.9 1,054 85 22.8% 8.1% — — 23.6% 33.2%
2 532067 3B BlackBio ₹1,205.90 1,166 18.8 153 56 34.9% 36.7% 47.1% 25.7% 50.7% -29.0%
3 514330 One Global ₹139.00 1,043 3.7 513 74 19.1% 14.5% 311.6% 288.9% 16.8% 43.0%
4 HEALTHX Health X ₹306.95 976 — 0 -1 -390.4% -376.2% — — -20.0% -367.5%
5 526546 Choksi Laboratories ₹61.93 146 19.9 47 2 26.8% 4.6% 10.1% 28.8% 7.5% 49.3%
6 540788 Aspira Pathlab ₹31.00 107 — 26 -0 3.8% -1.7% 13.5% -97.1% 17.5% -108.5%
7 530897 NG Industries ₹165.30 39 28.7 17 2 11.1% 11.4% -0.9% -77.7% 13.8% 104.3%
8 524602 Bandaram Pharma ₹30.99 33 162.8 79 1 4.8% 1.5% 70.2% -46.9% 195.7% 3322.0%
9 524548 Sharma East ₹50.09 32 13.9 37 1 9.6% 3.2% 20.3% 0.0% 13.7% -18.7%
10 542248 Deccan Health ₹35.53 30 34.8 82 3 6.4% 3.1% 9.1% 115.7% -0.3% 21.3%
11 539267 Samsrita Labs ₹17.13 28 — — — — — — — — —
12 523489 Chennai Meenakshi ₹34.47 28 — 37 -0 1.5% -1.1% 6.4% 16.1% -0.7% 100.4%
13 539428 Tejnaksh Healthcare ₹23.46 27 38.5 11 1 26.5% 11.3% -16.3% -47.5% 0.5% 24.1%
14 526139 Transgene Biotek ₹9.56 21 — 0 -2 -223.0% -766.2% -25.9% -146.3% 20.0% 9.5%
15 516110 Family Care ₹7.44 11 — 0 -8 -1321.3% -3505.7% -97.3% 80.3% 150.0% 39.5%
16 534422 Looks Health ₹5.73 10 177.4 0 0 41.2% 7.5% -2.6% 0.0% 75.7% —
17 531043 Dhanvantri Jeevan ₹19.95 10 16.1 28 1 3.2% 1.8% 14.2% -23.5% 41.6% 200.0%
18 526504 Dolphin Medical ₹1.85 10 5.2 1 0 13.0% 7.4% -2.6% 333.3% 21.2% -40.7%
19 541299 Dr Lalchandani ₹27.60 7 345.0 4 0 9.3% 1.7% — — -8.6% -148.1%
20 526187 Ashram Online.Com ₹6.29 7 — 1 -0 -74.9% -20.3% 33.3% -71.4% 31.6% 40.2%
❓ Frequently asked questions
What was One Global Service Provider Ltd's revenue in Q1 FY27?
One Global Service Provider Ltd reported revenue of ₹103 crore for the quarter ended June 2026 (Q1 FY27), up 16.8% from ₹88 crore in the same quarter last year, and down 23.3% sequentially over the March 2026 quarter.
What was One Global Service Provider Ltd's net profit in Q1 FY27?
Net profit rose 43.0% year-on-year to ₹14 crore, from ₹10 crore. Earnings per share (EPS) came in at ₹7.32.
What is 514330's market capitalisation and P/E ratio?
At the current price of ₹521.45, 514330 has a market capitalisation of ₹1,043 crore and a trailing P/E of about 14.0.
Who owns One Global Service Provider Ltd? (shareholding pattern)
As of Jun 2026, promoters held 68.40%, foreign institutional investors (FIIs) 7.72%, domestic institutional investors (DIIs) 0.01%, public shareholders 23.87% of One Global Service Provider Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI